Usefulness of Midline Catheters versus Peripheral Venous Catheters in an Inpatient Unit: A Pilot Randomized Clinical Trial

Author:

Villalba-Nicolau MarcelaORCID,Chover-Sierra ElenaORCID,Saus-Ortega CarlosORCID,Ballestar-Tarín Maria LuisaORCID,Chover-Sierra Pilar,Martínez-Sabater AntonioORCID

Abstract

Canalization of vascular accesses is one of the most used techniques in hospitalization units. When talking about peripherally inserted catheters, we can differentiate between peripheral intravenous catheters (PIVC), midline catheters, and long peripheral catheters (LPC). Midline catheters are rarely used despite being recommended for intravenous therapies lasting more than six days. This research is a pilot study of a longitudinal clinical trial. It aims to compare the complications associated with intravenous therapy between the control group (CG) with a PIVC and the experimental group (EG) with a midline in an Internal Medicine Unit of a Spanish hospital for three months. In this study, 44 subjects participated, 25 in the CG and 19 in the EG. The duration of cannulation was longer in the experimental group (8.13 days vs. 3.22, p < 0.001), and the appearance of phlebitis was more significant in the control group (19 patients in CG and 25 patients in EG). Midlines have presented a longer duration of cannulation and fewer complications than the PIVC. This protocol was registered with ClinicalTrials.gov (NCT05512117).

Funder

Fundación de Investigación del Hospital General Universitario

Publisher

MDPI AG

Subject

General Nursing

Reference42 articles.

1. Vascular Access in Hospitalized Patients;Hosp. Med. Clin.,2016

2. Better With Ultrasound;Chest,2019

3. Safety and efficacy of vasopressor administration through midline catheters;J. Crit. Care,2020

4. Indications for peripheral, midline and central catheters: Summary of the MAGIC recommendations;Br. J. Nurs.,2016

5. Decreasing Central Line–Associated Bloodstream Infections Acquired in the Home Setting Among Pediatric Oncology Patients;J. Pediatr. Oncol. Nurs.,2020

Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3